ArticleAntimicrobial agents and chemotherapy2015

Cellular pharmacokinetics and intracellular activity of the novel peptide deformylase inhibitor GSK1322322 against Staphylococcus aureus laboratory and clinical strains with various resistance phenotypes: studies with human THP-1 monocytes and J774 murine macrophages.

Frédéric Peyrusson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.